ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 305767 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 305767; 2) Community: the network communities that were significantly associated with the response to NSC 305767; 3) Molecule: the relationships between components within communities and NSC 305767; 4) MDR: the compounds that were significantly associated with the NSC 305767.

NSC Compound Enrichment Correlation
NSC 184692 Aminopterin Derivative 0.0314734733353265 0.59060683
NSC 221266 Benzoic acid, 3,4-dichloro-, [1-[4-[(3-amino-2,3,6-trideoxy-.alpha.-L-lyxo-hexopyranosyl)oxy]-1,2,3,4,6,11-hexahydro-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-2-naphthacenyl]ethylidene]hydrazide, monohy 0.0314734733353265 0.1174991
NSC 243022 Cinerubin A hydrochloride 0.0314734733353265 0.24548413
NSC 245398 Null 0.0314734733353265 0.10946842
NSC 282880 Ethanaminium, 2-[[hydroxy(octadecyloxy)phosphinyl]oxy]-N,N,N-trimethyl-, inner salt (9CI) 0.0314734733353265 0.14270433
NSC 351907 MASTOPARAN 0.0314734733353267 0.074522548
NSC 46401 .alpha.-Sarcin 0.0314734733353267 -0.032570527
NSC 624659 ANTINEOPLASTIC-624659 0.0314734733353267 0.26383425
NSC 625500 Null 0.0314734733353267 0.15158366
NSC 626030 Naphth[2,3-d]oxazol-4-one, 2-(1,1-dimethylethyl)-9-[(4- fluorophenyl)imino]- 0.0314734733353267 0.30245142
Total:106  Current:77    [First] [Prev] [Next] [Last]